Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus
Transplantation, 2014•journals.lww.com
Background Islet transplantation is a recognized treatment option for select patients with
type I diabetes mellitus. However, islet infusions from multiple donors are often required to
achieve insulin independence. Ideally, insulin independence would be achieved routinely
with only a single donor. Identification of factors associated with insulin independence after
single-donor islet transplantation may help to select recipient-donor combinations with the
highest probability of success. Methods Subjects undergoing islet transplantation at a single …
type I diabetes mellitus. However, islet infusions from multiple donors are often required to
achieve insulin independence. Ideally, insulin independence would be achieved routinely
with only a single donor. Identification of factors associated with insulin independence after
single-donor islet transplantation may help to select recipient-donor combinations with the
highest probability of success. Methods Subjects undergoing islet transplantation at a single …
Abstract
Background
Islet transplantation is a recognized treatment option for select patients with type I diabetes mellitus. However, islet infusions from multiple donors are often required to achieve insulin independence. Ideally, insulin independence would be achieved routinely with only a single donor. Identification of factors associated with insulin independence after single-donor islet transplantation may help to select recipient-donor combinations with the highest probability of success.
Methods
Subjects undergoing islet transplantation at a single center (Edmonton, Canada) between March 1999 and August 2013 were included. Recipient, donor, and transplant characteristics were collected and compared between recipients who became insulin independent after one islet transplantation and those who did not.
Results
Thirty-one patients achieved insulin independence after a single-donor islet transplantation, and 149 did not. Long-term insulin-free survival was not different between the groups. Factors significantly associated with single-donor success included recipient age, insulin requirement at baseline, donor weight, donor body mass index, islet transplant mass, and peritransplant heparin and insulin administration. On multivariate analysis, pretransplantation daily insulin requirements, the use of peritransplantation heparin and insulin infusions, and islet transplant mass remained significant.
Conclusion
We have identified clinically relevant differences defining the achievement of insulin independence after single-donor transplantation. Based on these differences, a preoperative insulin requirement of less than 0.6 U/kg per day and receiving more than 5,646 islet equivalents (IEQ)/kg have a sensitivity of 84% and 71% and specificity of 50% and 50%, respectively, for insulin independence after single-donor islet transplantation. With ideal patient selection, this finding could potentially increase single-donor transplantation success and may be especially relevant for presensitized subjects or those who may subsequently require renal replacement.
Lippincott Williams & Wilkins